Does Dupixent List Joint Pain as a Side Effect?
Dupixent (dupilumab) can cause joint pain in some patients. Clinical trials and post-marketing reports identify arthralgia (joint pain) as a reported adverse reaction, occurring in 2-10% of patients depending on the condition treated, such as atopic dermatitis or asthma. This is higher than placebo rates in studies.[1][2]
How Common Is Joint Pain with Dupixent?
- In atopic dermatitis trials, joint pain affected about 7% of adults on Dupixent versus 2% on placebo.
- For asthma patients, rates were around 4-5%.
- It's more frequent in adults over 65 and those on higher doses or combination therapies like corticosteroids.[1][3]
These figures come from Dupixent's prescribing information and FDA-approved labeling.
Why Does Dupixent Cause Joint Pain?
The exact mechanism isn't fully known, but Dupixent blocks IL-4 and IL-13 signaling, which may disrupt immune regulation in joints. Some cases link to serum sickness-like reactions or eosinophil changes. It often starts weeks to months after treatment begins and can resolve upon discontinuation.[2][4]
How Long Does Joint Pain Last and What Helps?
Pain typically appears within 1-3 months and may persist during treatment. Management includes NSAIDs, dose adjustments, or switching therapies. Severe cases warrant stopping Dupixent and consulting a doctor—report via FDA MedWatch.[1][3]
Is Joint Pain More Likely in Certain Patients?
Patients with asthma, COPD, or eosinophilic conditions face higher risks (up to 10%). Those tapering oral steroids may experience arthralgia as part of withdrawal. Pre-existing arthritis increases susceptibility.[2][4]
What Do Patients Report About Joint Pain?
Real-world data from forums and FAERS database show complaints of knee, hip, and hand pain, sometimes severe enough to limit mobility. Some describe it as inflammatory arthritis-like, with a few cases of confirmed joint inflammation on exam.[5]
Alternatives If Joint Pain Occurs
For atopic dermatitis, consider biologics like Adbry (tralokinumab) or JAK inhibitors like Cibinqo, which have lower joint pain rates in trials. Always discuss with a dermatologist or allergist.[1][6]
[1]: Dupixent Prescribing Information (FDA)
[2]: Drugs.com - Dupixent Side Effects
[3]: ClinicalTrials.gov - Dupixent Studies (e.g., NCT01859988)
[4]: Journal of Allergy and Clinical Immunology - Dupilumab Musculoskeletal Effects
[5]: FDA FAERS Database
[6]: GoodRx - Dupixent Alternatives